Latest antivirals News

‘Atomic snapshots’ of proofreading enzyme could lead to better COVID-19 drugs
Message from the Head of the PIP Framework Secretariat, Anne Huvos
Message from the Head of the PIP Framework Secretariat, Anne Huvos
One-two punch: flu treatment protects lungs & minimises pneumonia
Fighting Two Infections At Once
Awareness week highlights dangers of superbugs and drug-resistant infections
Awareness week highlights dangers of superbugs and drug-resistant infections
Wanda Christ Awarded Sven Gard´s Scholarship 2025
Updated WHO dashboard offers new insights on antimicrobial resistance and use
Act now to end viral hepatitis in NSW – A call to action on World Hepatitis Day
WHO recommends rapid treatment initiation for people living with HIV and mpox
WHO-backed integrated testing model strengthens response to mpox, HIV, and syphilis
NSW residents urged to act as COVID levels rise on top of influenza
New formula may reduce shingles, cold sore pain
Genital herpes is on the rise. Here’s what to know about this common infection
Support Your Older Community To Stay Well This Holiday Season
Empowering First Nations communities with culturally appropriate COVID-19 resources to improve awareness of antiviral treatments
Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
New study reveals gaps in antimicrobial knowledge and planetary health education
FluMist: Who Is Nasal Spray Best For?
Antiviral-resistant SARS-CoV-2 variants can emerge in immunocompromised people
Antiretroviral therapies impact gut microbiome in people living with HIV
Act now to end viral hepatitis in NSW – A call to action on World Hepatitis Day
Joe Biden has COVID. Here’s what someone over 80 can expect
What’s the difference between ‘man flu’ and flu? Hint: men may not be exaggerating
Govt Strengthens COVID-19 Preparedness
Multiple sclerosis: blood test that tracks immune response could be first step in developing better treatments
WHO announces forthcoming updates on co-administration of treatment for drug-resistant tuberculosis and hepatitis C
2023: outbreaks of avian influenza
WHO to begin development of parallel recommendation and regulatory pathways; shortening the time taken for people to access health products
Three NYU Studies Vie for This Year’s Top Health Discovery
Cow has potential as therapeutic research model
Protecting older people in festive season
Should we still be using RATs to test for COVID? 4 key questions answered
Contagious omicron strain replicates early in infection
What you need to know about COVID, flu and RSV vaccines
Universal siRNA Covid treatment shows promise in lab
Total recall on HIV
Griffith University and Gene Company partner to create exciting RNA-based COVID anti-viral
City of Ballarat extends free Rapid Antigen Test scheme
Review of 2022 Covid winter surge package
Free Rapid Antigen Tests still available
Improving access to novel COVID-19 treatments
Estimating pandemic product needs and allocation levels
Here’s who decides cause of death, how death certificates work – and whether a person died with or of COVID
Free Covid Rapid Antigen Tests available to all Ballarat residents
More Free RATS Now Available Through Your Local Council
Omicron subvariant XBB.1.5 detected in New Zealand